Meta analysis of Guizhi Fuling Pills combined with Gestrinone in the treatment of adenomyosis
TANG Lei1 WANG Guohua2 PANG Ying3 LIU Yuxin1
1.The Third Clinical Medical College, Beijing University of Chinese Medicine, Beijing 100029, China;
2.Department of Gynaecology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, China;
3.the First Clinical Medical College, Beijing University of Chinese Medicine, Beijing 100029, China
Abstract:Objective To systematically evaluate the clinical efficacy of Guizhi Fuling Pills combined with Gestrinone in the treatment of adenomyosis. Methods All randomized controlled trials about Guizhi Fuling Pills combined with Gestrinone in the treatment of adenomyosis were collected by computer search supplemented by manual search of CNKI, Wanfang, VIP, PubMed, Cochrane Library, Web of Science, and SinoMed. The search date was from inception to November 2021. Two researchers independently screened the literature, and performed meta analysis and bias statistical analysis through Review Manager 5.3 and Stata 12.0 software. Results A total of 489 patients were included in five literatures. The results of meta analysis showed that the total effective rate of the experimental group was higher than that of the control group (RR = 0.18, 95%CI: 0.08-0.28, P = 0.000 3), the levels of carbohydrate antigen 125 (MD = -14.81, 95%CI: -17.41 to -12.21, P < 0.000 01), visual analogue scale score (SMD = -2.91, 95%CI: -3.22 to -2.59, P < 0.000 01) and pictorial blood loss assessment chart score (MD = -39.32, 95%CI: -41.55 to -37.08, P < 0.000 01) in the experimental group were lower than those in the control group. Conclusion Guizhi Fuling Pills combined with Gestrinone is reliable in the treatment of adenomyosis, but more high-quality randomized controlled trials are needed to provide clinical evidence.
唐磊1 王国华2 庞颖3 刘雨昕1. 桂枝茯苓丸中成药联合孕三烯酮治疗子宫腺肌病的meta分析[J]. 中国医药导报, 2022, 19(25): 133-136,145.
TANG Lei1 WANG Guohua2 PANG Ying3 LIU Yuxin1. Meta analysis of Guizhi Fuling Pills combined with Gestrinone in the treatment of adenomyosis. 中国医药导报, 2022, 19(25): 133-136,145.